Antibody-drug conjugates (ADCs) are fusions of therapeutic drugs and antibodies conjugated by a linker, designed to deliver a therapeutic payload to cells expressing the target antigen. By delivering ...

A single drug shrank or eliminated tumors in 43 of 102 patients with advanced head-and-neck cancer that had stopped ...

Researchers at The University of Texas MD Anderson Cancer Center identified an immune pathway that may promote the ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Two new studies, published ...

Human Papillomavirus now causes many head and neck cancers, not only cervical cancer. Certain high-risk HPV strains persist ...

A large clinical study recently published in The Lancet showed that patients treated with proton therapy for oropharyngeal cancers (cancers of the upper throat including the tonsils and back of the ...

Researchers at The University of Texas MD Anderson Cancer Center identified an immune pathway that may promote the progression of oral precancerous lesions into head and neck squamous cell carcinoma.

(Boston)—Head and neck squamous cell carcinomas (HNSCC) are the seventh most prevalent form of cancer and are associated with human papilloma virus infection (HPV-positive) or with tobacco and alcohol ...

Medical imaging routinely used in cancer care may hold far more biological information than previously thought. An international study involving Umeå University guest professor Lukas Kenner shows that ...

PYXS’ micvotabart pelidotin faces head & neck cancer competition, side effects and funding risk. See fall 2026 catalyst, ...